Clinical Trials Browser

Phase 4 × Dalteparin × Tumor-Agnostic × Clear all

NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Phase 4 Completed

338 enrolled 21 charts

Neoplasms